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Introduction
Diseases of circulatory system, in particular cardiovascular dis-
eases, have been the leading cause of death worldwide for many 
years.1) At the beginning of the 20th century, cardiovascular dis-
eases accounted for less than 10% of all deaths worldwide. Now, 
early in the 21st century, they account for nearly one half of all 
deaths in the developed world and 25% in the developing world.2) 
In Korea, cerebrovascular and cardiovascular diseases rank first 
and second for mortality from single-organ diseases.3) An under-
standing of cardiovascular disease mortality patterns can be 
gained from analyzing national data representative of the popula-
tion, and may be important in developing strategies for reducing 
mortality from cardiovascular diseases. Cardiovascular disease 
trends have been reported in many countries. However, there is 
only limited information on the trends of mortality from cardio-
vascular diseases in the Korean population. Thus, we examined the 
changing pattern of cardiovascular disease mortality in Korea dur-
ing a 30-year period using Cause of Death statistics from Statistics 
Korea.4)
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Materials and Methods
Annual mortality data were obtained from Korean Statistical In-
formation Service managed by Statistics Korea (formerly known as 
Korea National Statistical Office). Mortality statistics with cause of 
death information were available from 1983 to 2012. Causes of 
death were coded according to the International Classification of 
Disease, 10th Revision. For the purpose of this study, one category 
was analyzed for circulatory system diseases. For cardiovascular 
diseases, five categories were used: total heart diseases (I00-13 
and I20-51), acute rheumatic fever and chronic rheumatic heart 
disease (I00-I09), hypertensive heart disease (I10-I13), ischemic 
heart disease (IHD, I20-I25), and atherosclerosis of arteries other 
than carotid or cerebral artery (I70)  (Table 1).
The total heart diseases category (I26–I51) includes acute and 
chronic rheumatic heart disease, hypertensive heart disease, isch-
emic heart disease and other heart diseases. Acute rheumatic fever 
and chronic rheumatic heart diseases (I00-I09) includes rheumatic 
fever without mention of heart involvement (I00), rheumatic fever 
with heart involvement (I01), rheumatic chorea (I02), rheumatic 
mitral valve diseases (I05), rheumatic aortic valve diseases (I06), 
rheumatic tricuspid valve diseases (I07), multiple valve diseases 
(I08), and other rheumatic heart diseases (I09). Hypertensive heart 
disease (I10-I13) includes essential primary hypertension (I10), hy-
pertensive heart disease (I11), hypertensive renal disease (I12), and 
hypertensive heart and renal disease (I13). The ischemic heart dis-
eases category (I20-I25) includes angina pectoris (I20), acute 
myocardial infarction (I21), subsequent myocardial infarction (I22), 
certain current complications following acute myocardial infarc-
tion (I23), other acute ischemic heart diseases (I24), and chronic 
ischemic heart disease (I25). Atherosclerosis (I70) includes athero-
sclerosis of the aorta (I70.0), atherosclerosis of the renal artery 
(I70.1), atherosclerosis of arteries of the extremities (I70.2), athero-
sclerosis of other arteries (I70.8), and generalized and unspecified 
atherosclerosis (I70.9).
We calculated the age-adjusted mortality rate for cardiovascular 
disease using the direct standardization method, with the age dis-
tribution in 2000 used as the standard population. We analyzed 
data with 10-year age intervals and used the same population 
structure for standardization in men and women to compare mor-
tality by sex. We also presented penalized B-splines to explore the 
patterns of the crude death rate and age-adjusted death rate per 
100000. Penalized regression methods were used that use a suit-
able penalty functional to quantify the notion of roughness of a 
curve, with a necessary compromise between bias and variability 
in curve fitting.5) 
Results
Mortality from diseases of circulatory system
Over the last 30 years, the crude mortality rate from diseases of 
the circulatory system has shown little change. By 1992, the crude 
Table 1. Classification of the cause of death statistics
Disease of circulatory system (I00-99)
Total heart diseases (I00-13 and I20-51)*
 Acute rheumatic fever and chronic rheumatic heart disease (I00-I09)*
Hypertensive heart disease (I10-I13)*
Ischemic heart disease (I20-I25)*
Other heart diseases (I26-25)
Cerebrovascular disease (I60-69)
Atherosclerosis of arteries other than carotid or cerebral artery (I70)*
Other circulatory diseases (I71-99)
*Cause-specific mortality calculated in this study
Fig. 1. Crude and age-adjusted mortality from diseases of the circulatory system.
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mortality rate for men was higher than for women, but this gender 
gap gradually decreased, and post-1992 the mortality rate has 
been higher for women. The crude mortality rate from circulatory 
system diseases was 187.0 per 100000 men and 144.5 per 100000 
women in 1983. The rate has decreased to 110.4 per 100000 men 
and 123.8 per 100000 women in 2012. The mortality rate has seen 
a 41.3 % decrease in men and 14.3 % decrease in women during 
the 30 years (Fig.1A).
The age-adjusted mortality rate has also decreased, but the rate 
has consistently been higher in men than in women. In 1983, the 
age-adjusted mortality rate from circulatory system diseases was 
305.7 per 100000 men and 160.4 per 100000 women. The age-ad-
justed mortality rate per 100000 was 65.7 for men (decreased by 
78.5%) and 38.0 for women (decreased by 76.3%) in 2012 (Fig. 1B). 
Mortality from total heart diseases
The crude mortality rate from heart disease showed a downward 
trend up to the early 2000s, but thereafter showed a slight upward 
trend. In the 1980s, the crude mortality rate for men was higher 
than for women, but the gender difference gradually decreased 
and eventually reversed by the 2000s. The crude mortality rate 
from heart disease in 1983 was 110.2 per 100000 in men and 80.1 
per 100000 women. By 2012, the crude mortality rate per 100000 
was 58.5 for men and 68.3 for women. During this 30-year period 
there has been a 46.9 % decrease in men and 14.7 % decrease in 
women (Fig. 2A). 
The age-adjusted mortality rate consistently decreased in both 
men and women. The age-adjusted mortality rate rapidly decreased 
until the early 2000s, and has stabilized thereafter in both sexes. 
Unlike crude mortality, the age-adjusted heart disease mortality 
rate has been consistently higher in men than in women. The 
age-adjusted mortality rate per 100000 from heart disease in 
1983 was 175.5 for men and 89.2 for women. In 2012, the age-
adjusted mortality rate per 100000 was 35.3 for men and 20.0 
for women. Therefore the rate saw a 79.9% decrease in men and 
a 77.6 % decrease in women over the 30-year period (Fig. 2B).
Mortality from IHD
There was a significant increase in IHD mortality over the 30-
year period analyzed in this study. The crude IHD mortality rate 
rapidly increased until the mid-2000s and fluctuated thereafter in 
both sexes. The crude mortality rate was 3.0 per 100000 in 1983 
and 30.6 per 100000 in 2012 in men. In women, the rate was 1.6 
per 100000 in 1983 and 27.3 per 100000 in 2012 (Fig. 3A). The 
age-adjusted mortality rate increased until the early 2000s, after 
which there was a gradual decrease amongst both sexes. The age-
adjusted mortality rate per 100000 in 1983 was 4.7 for men and 
1.9 for women. In 2012, the age-adjusted mortality rate per 
100000 was 18.4 for men and 8.1 for women. From the time of the 
highest age-adjusted mortality rates in 2002, there was about a 30 
% decrease in men and a 37 % decrease in women until 2012 (Fig. 
3B). During the entire period, the male-to-female ratio for crude 
IHD mortality was relatively small but the ratio was around 2.0 for 
age-adjusted IHD mortality (Fig. 3).
We displayed fitted lines with confidence limits for crude and age-
adjusted IHD mortalities, separately for men and women, using a pe-
nalized B-splines method. We also presented vertical reference lines 
that indicate the peaks of each fitted death rate. Although crude IHD 
mortality showed fluctuations after the mid-2000s, the estimated 
peak IHD mortality was observed in the last year of observation 
Men Women Men Women
Fig. 2. Crude and age-adjusted mortality from total heart diseases.
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Fig. 3. Crude and age-adjusted mortality from ischemic heart diseases.
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Fig. 4. Crude and age-adjusted mortality from ischemic heart diseases fitted by penalized B-splines method. Solid lines, gray shadows and blue dash lines 
represent the estimated death rates, 95% confidence intervals and 95% prediction intervals. The estimated death rates were calculated by using the penal-
ized regression method. The 95% confidence interval means that the possibility of population death rates lying within these bands (shades) is 95%, while 
the 95% prediction Interval means that the possibility of a specific observation lying within these bands (dashed lines) is 95% when we are interested in a 
specific observation (i.e. independent variable: time). Vertical reference lines indicate peaks of each fitted death rate.
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(2012) (Fig. 4A and B). In contrast, age-adjusted IHD mortality 
reached its peak in 2002 in men and 2003 in women, after which 
there was a decreasing pattern in both sexes (Fig. 4C and D). Re-
sults of penalized regression splines for other cardiovascular dis-
eases are provided as supplemental data (Supplementary Figs. 1 
to 5).
Mortality from rheumatic heart disease, hypertensive heart 
disease, and atherosclerosis
Crude mortality rates from acute rheumatic fever or chronic 
rheumatic heart disease showed fluctuations, but the rates did not 
exceed 1.0 per 100000 population. The rates for women were slight-
ly higher than for men overall (Fig. 5A). Deaths from hypertensive 
diseases rapidly decreased during the 1980s, and have gradually sta-
bilized since the 1990s. The crude mortality was as high as 57.4 per 
100000 men and 37.0 per 100000 women in 1983, but subsequently 
decreased by around by 90% in men and by 60% in women (Fig. 
5B). The crude mortality rate from atherosclerosis showed a rapid 
increase until the early 1990s, then a rapid decrease until the late 
1990s, and finally leveled off in the 2000s (Fig. 5C). 
Discussion
Our study reports the deaths rates of major cardiovascular dis-
eases in the Korean population and their trends over a 30-year pe-
riod (1983 until 2012). Mortality from diseases of the circulatory 
system significantly decreased during this period and the decreas-
ing trend was more prominent in men than in women. Heart dis-
ease mortality also showed a marked decrease. 
Our study also indicates a decreasing trend in mortality from 
hypertensive disease. The decrease in hypertensive disease mortal-
ity could be largely attributed to improved management of hyper-
tension. Although the prevalence of hypertension did not signifi-
cantly change, the age-adjusted prevalence of hypertension and 
the mean blood pressure level among Korean adults have signifi-
cantly decreased over the last few decades.6)7) 
On the other hand, IHD mortality increased remarkably. During 
the most recent few years of observation, IHD mortality did not 
significantly increase, but it did not decrease either. In our further 
analysis with penalized regression splines, the highest IHD mortali-
ty was observed in the last year of observation. This implies that 
the crude mortality rate of IHD is still increasing. The Korean 
Fig. 5. Crude mortality rates from rheumatic heart disease (A), hyperten-
sive disease (B), and atherosclerosis (C).
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population is expected to face an increasing disease burden from 
IHD, even though the IHD mortality in Korea is still lower than 
those of people in Western countries.8)9) 
Fortunately, age-standardized mortality from IHD showed a de-
crease during the last 10 years in our study. Thus, the increase in 
the absolute number of deaths from IHD can be largely explained 
by the rapid aging of the Korean population.
Decreasing trends of IHD mortality have been reported in many 
high-income countries.10-13) Studies for those countries suggest 
that even modest changes in major population risk factors such as 
smoking, hypertension, and lipid levels have had the greatest ef-
fect in decreasing cardiovascular mortality. However, increasing 
rates of obesity, diabetes, and sedentary lifestyles threaten to un-
dermine these trends.14)15)  
The decreasing trends of cardiovascular disease mortality may 
be attributed to lifestyle changes that affect the risk of cardiovas-
cular disease.16) In general, risk factors for cardiovascular disease 
include demographic characteristics, family history of cardiovas-
cular disease, cigarette smoking, physical inactivity, abnormal se-
rum lipids, obesity, hypertension, and diabetes mellitus.17) A recent 
study has reported trends in the prevalence of major risk factors 
for cardiovascular disease using data from the Korea National 
Health Nutrition Examination Survey for years 1998 through 
2012.6) In this study, the prevalence of hypertension decreased in 
both men and women, whereas the prevalence of hypercholester-
olemia significantly increased in both men and women. Smoking 
rates decreased only in men, whereas the prevalence of diabetes 
did not change over time. The prevalence of obesity significantly 
increased only in men.6) In the United States, the mortality from 
coronary heart disease in men aged 25-44 in the United States 
continuously decreased during 1985 through 1992.16) The decline 
of coronary heart disease was attributed to treatments (47%) and 
changes in risk factors (44%), including reductions in total choles-
terol, systolic blood pressure, smoking prevalence, and physical in-
activity. In another study of the United States, from 1980 through 
2000 the age-adjusted death rate for coronary heart disease de-
creased significantly among adults 25 to 84 years old.11) 
The trends in incidence rates of cardiovascular disease have 
been studied in many countries other than Korea. In the Unites 
states, from 1987 to 1994, the incidence of those hospitalized for 
myocardial infarction showed either stable or slightly increasing 
trends.18) However, there were significant annual decreases in mor-
tality from coronary heart disease. It was suggested that the de-
cline in mortality for myocardial infarction might be due largely 
to improvements in the treatment and secondary prevention of 
myocardial infarction. In Japan, a country geographically close to 
Korea, the MIYAGI-AMI Registry Study also reported a steady 
trend of increasing incidence, but decreasing mortality, for acute 
myocardial infarction from 1979 to 2008.19) In a Korean study of 
incidence trends from acute myocardial infarction using the Kore-
an National Health Insurance database, incidence of acute myo-
cardial infarction increased between 1997 and 2007.20) However, 
in contrast to this, another study that analyzed National Health 
Insurance claim data reported that both crude and age-stan-
dardized incidence rates of acute myocardial infarction de-
creased between 2006 and 2010.21) Considering previous studies 
and our study, the current decline or stable trend in IHD mortali-
ty may be due largely to improvements in treatment of myocar-
dial infarction and to secondary prevention rather than to a de-
cline of incidence rates. Future efforts to reduce IHD mortality 
rates have to include better primary prevention as well as more 
timely access to medical care. At the same time, improving the 
quality of care is also required through long-term monitoring 
and an adequate registry system.22)    
In the present study, crude mortality rates from cardiovascular 
diseases were higher in men than those in women during the 
earlier years. But the consistently higher rates of cardiovascular 
mortality amongst men saw a change from the early 1990s, with 
the mortality rates for women climbing above rates for men. This 
change is probably due to the phenomenon that life expectancy 
is increasing faster in Korean women than in Korean men.23) The 
male-to-female ratio in age-adjusted mortalities did not signifi-
cantly change. When the age distribution was standardized, 
overall cardiovascular mortalities were always higher in men 
than in women. More specifically, age-adjusted IHD mortalities 
have been consistently two times higher in men than in women, 
and this difference between the sexes is consistent with previous 
observations.24-26) Among Korean patients with ST-segment ele-
vation myocardial infarction,27) women had a higher risk of fatal-
ity than men. But the study suggested that the sex difference in 
the fatality rate was due mostly to age and clinical history, not 
gender itself.
The major strength of the present study is that it analyzed na-
tionwide mortality data for the Korean population over a 30-year 
period. However, there are also several limitations to be discussed. 
First, the validity of cause of death can be debated. Statistics Korea 
annually reports the Cause of Death Statistics,4) and the database 
is primarily based on death certificates. However, causes of death 
in the database are subject to misclassification. A previous study 
retrospectively compared the Cause of Death Statistics4) with 
hospital medical records, and reported the overall accuracy of 
causes of death as 91.9%.28) Second, there are still a significant 
number of deaths recorded without underlying causes in the 
Cause of Death Statistics database. In 2012, an overall 9.4% of 
208 Cardiovascular Diseases Mortality in Korea
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deaths were classified as unknown causes, although deaths of un-
known cause are decreasing. Thus, there is a possibility that mor-
tality from cardiovascular disease has been underestimated. Third, 
the reported number of cardiovascular deaths can be influenced 
by the health care system. Over the last few decades, Korea has 
experienced a marked improvement in medical service accessibility 
and health care technologies. These changes may have affected 
the reported number of cardiovascular diseases. Lastly, there is no 
available nationwide data on the incidence of cardiovascular dis-
eases, so we cannot explore the substantial causes of changing 
mortality trends. 
Conclusion
Even though total cardiovascular disease mortality rates have 
significantly decreased during the 30-year period of study, the IHD 
mortality rate continuously increased until recently. Prevention 
and management of cardiovascular diseases amongst the Korean 
population, especially for IHD, still remains a great challenge. In 
order to meet this challenge, continuous monitoring of the mor-
tality trends for cardiovascular diseases is required.
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